
Package Leaflet: Information for the Patient
Dutasteride/Tamsulosin Teva-ratio 0.5 mg/0.4 mg hard capsules EFG
Dutasteride/Tamsulosin hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Dutasteride/Tamsulosin is used in men to treat an enlarged prostate (benign prostatic hyperplasia) - a non-cancerous growth of the prostate caused by overproduction of a hormone called dihydrotestosterone.
Dutasteride/Tamsulosin is a combination of two different medicines called dutasteride and tamsulosin. Dutasteride belongs to a group of medicines called 5-alpha reductase inhibitors and tamsulosin belongs to a group of medicines called alpha blockers.
As the prostate grows, it can cause urinary problems such as difficulty in the flow of urine and a need to urinate more frequently. It can also cause the urine stream to be weaker and less forceful. If left untreated, benign prostatic hyperplasia can lead to a risk of the urine flow being completely blocked (acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or to remove it.
Dutasteride reduces the production of dihydrotestosterone, which helps to reduce the size of the prostate and relieve symptoms. This reduces the risk of acute urinary retention and the need for surgery. Tamsulosin works by relaxing the muscles in the prostate, making it easier to urinate and quickly improving symptoms.
Do not takeDutasteride/Tamsulosin Teva-ratio:
If you think you may have any of these conditions, do not takethis medicine until you have consulted your doctor.
Warnings and precautions
Consult your doctor before starting to take dutasteride/tamsulosin.
Consult your doctor or pharmacist if you have any questions related to taking dutasteride/tamsulosin.
Using dutasteride/tamsulosin with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Do not take dutasteride/tamsulosin with these medicines:
It is not recommended to take dutasteride/tamsulosin with these medicines:
Certain medicines may interact with dutasteride/tamsulosin, which may increase the risk of you experiencing side effects. Some of these medicines are:
Tell your doctor if you are taking any of these medicines.
Taking dutasteride/tamsulosin with food and drink
You should take dutasteride/tamsulosin 30 minutes after the same meal each day.
Pregnancy, breastfeeding, and fertility
Women should not take dutasteride/tamsulosin.
Pregnant women (or those who may be pregnant) should avoid contact with broken capsules. Dutasteride is absorbed through the skin and may affect the normal development of a male baby. This risk is especially important during the first 16 weeks of pregnancy.
Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking dutasteride/tamsulosin. If your partner is pregnant or thinks she may be pregnant, she should avoid exposure to your semen.
Dutasteride/tamsulosin has been shown to decrease sperm count, motility, and semen volume. This may reduce your fertility.
Consult your doctor if a pregnant woman has been in contact with dutasteride/tamsulosin.
Driving and using machines
Some people may experience dizziness during treatment with dutasteride/tamsulosin, which may affect their ability to drive or operate machinery safely.
Do not drive or operate machinery if you are affected in this way.
Dutasteride/Tamsulosin Teva-ratio contains soy lecithin
This medicine contains soy lecithin. It should not be used in case of peanut or soy allergy.
Dutasteride/Tamsulosin Teva-ratio contains propylene glycol
This medicine contains 299.46 mg of propylene glycol monocaprylate, type II in each capsule (equivalent to more than 1 mg/kg/day, but less than 50 mg/kg/day of propylene glycol) and traces of propylene glycol in the black ink.
Dutasteride/Tamsulosin Teva-ratio contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist.
If you do not take dutasteride/tamsulosin regularly, your PSA levels may be affected. If in doubt, consult your doctor or pharmacist again.
What dose should you take
The recommended dose is one capsule once a day, 30 minutes after the same meal each day.
How to take it
The capsules should be swallowed whole, with water. Do not chew or open the capsules. Contact with the contents of the capsules can irritate your mouth or throat.
If you take moredutasteride/tamsulosinthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to takedutasteride/tamsulosin
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
If you stop taking dutasteride/tamsulosin
Do not stop taking dutasteride/tamsulosin without consulting your doctor first.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reaction
Symptoms of an allergic reaction can include:
Contact your doctor immediately if you experience any of these symptoms and stop taking this medicine.
Dizziness, lightheadedness, and fainting
Dutasteride/tamsulosin may cause dizziness, lightheadedness, and, in rare cases, fainting. You should be careful when getting up quickly after sitting or lying down, especially if you need to get up during the night, until you know how this medicine affects you. If you feel dizzy or lightheaded during treatment, sit or lie down until these symptoms have disappeared.
Severe skin reactions
Signs of severe skin reactions can include:
Contact your doctor immediately if you have these symptoms and stop using this medicine.
Common side effects
These may affect up to 1 in 10 men:
Uncommon side effects
These may affect up to 1 in 100 men:
Rare side effects
These may affect up to 1 in 1,000 men:
Very rare side effects
These may affect up to 1 in 10,000 men:
Other side effects
Other side effects have been reported in a small number of men, but their exact frequency is unknown (the frequency cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.
Store below 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition ofDutasteride/Tamsulosine Teva-ratio
The active ingredients are dutasteride and tamsulosine hydrochloride. Each capsule contains 0.5 mg of dutasteride (in a soft capsule) and 0.4 mg of tamsulosine hydrochloride (as modified release pellets).
The other components are:
Hard capsule shell:
Black iron oxide (E172)
Red iron oxide (E172)
Titanium dioxide (E171)
Yellow iron oxide (E172)
Gelatin
Black ink (shellac, black iron oxide (E172), propylene glycol, ammonia solution, concentrated potassium hydroxide.
Contents of the soft dutasteride capsule:
Propylene glycol monocaprylate, type II (see section 2 "Dutasteride / Tamsulosine Teva-ratio contains propylene glycol")
Butylhydroxytoluene (E321)
Gelatin
Glycerol
Titanium dioxide (E171)
Triglycerides (medium chain)
Lecithin (may contain soybean oil) (see section 2 "Dutasteride / Tamsulosine Teva-ratio contains soy lecithin")
Contents of the tamsulosine pellets:
Copolymer of methacrylic acid and ethyl acrylate (1:1) dispersion 30 percent (contains sodium lauryl sulfate and polysorbate 80, see section 2 "Dutasteride / Tamsulosine Teva-ratio contains sodium")
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Hydrated colloidal silica
Calcium stearate
Appearance of the product and container contents
This medicinal product is presented in hard, oblong capsules, with a brown body and a beige cap, printed with C001 in black ink, approximately 24 mm in length.
Container sizes:
HDPE bottles: 7, 30, 90 and 180 (2 bottles of 90) capsules.
Only some container sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Teva Pharma, S.L.U.
Anabel Segura, 11
Albatros B building, 1st floor
28108 Alcobendas, Madrid (Spain)
Manufacturer:
Laboratorios LEON FARMA, S.A.
Navatejera Industrial Estate
La Vallina, s/n 24193 Navatejera – León
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Netherlands:Dutasteride/Tamsulosinehydrochloride Teva 0.5 mg/0.4 mg, hard capsules
Belgium:Dutasteride/Tamsulosine Teva 0.5 mg/0.4 mg hard capsules / capsules / Hartkapseln
Denmark:Dutasterid/Tamsulosin-ratiopharm 0.5 mg + 0.4 mg Hartkapseln
Estonia:Dutasteride/Tamsulosine Teva
Spain:Dutasterida/Tamsulosina Teva-ratio 0.5 mg/0.4 mg hard capsules EFG
Finland:Dutasteride/Tamsulosinhydrochlorid ratiopharm 0.5 mg/0.4 mg capsule, hard
France:Dutastéride/Tamsulosine Teva 0.5 mg/0.4 mg capsule
Hungary:Duster Duo 0.5 mg/0.4 mg hard capsules
Iceland:Dutasteride/Tamsulosin Teva
Luxembourg:Dutasterid/Tamsulosin-ratiopharm 0.5 mg + 0.4 mg Hartkapseln
Latvia:Dutasteride/ Tamsulosine Teva 0.5 mg/0.4 mg hard capsules
Poland:DUTATEV
Portugal:Dutasterida + Tansulosina Teva
Slovenia:Dutrex Combo 0.5 mg/0.4 mg hard capsules
Dateof the last revision of this prospectus:July 2019
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of DUTASTERIDE/TAMSULOSIN TEVA-RATIO 0.5 mg/0.4 mg HARD CAPSULES in November, 2025 is around 20.15 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DUTASTERIDE/TAMSULOSIN TEVA-RATIO 0.5 mg/0.4 mg HARD CAPSULES – subject to medical assessment and local rules.